Law FirmOpposition Filing Analysis

The comprehensive analysis of Pohlman opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Pohlman

Patent NumberTitleApplicantOpposition DateOpposition Company
Composition For Nasal Application With Improved StabilityMARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFTFeb 26, 2025RATIOPHARM
Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous RegulatorsTHE UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRSJan 15, 2025DORRIES
Cell Culture MethodsUCB BIOPHARMADec 23, 2024POHLMAN
Recombinant Proteins Derived From Genus Limulus, And Dna Molecules Encoding SameSEIKAGAKUNov 22, 2024POHLMAN
Methods For Treating Skin Infection By Administering An Il-4R AntagonistREGENERON PHARMACEUTICALSNov 13, 2024DORRIES
Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorREGENERON PHARMACEUTICALSNov 7, 2024DORRIES
Methods For Isolating, Culturing, And Genetically Engineering Immune Cell Populations For Adoptive TherapyJUNO THERAPEUTICSOct 29, 2024POHLMAN
Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of ComplementALEXION PHARMACEUTICALSOct 28, 2024AMGEN TECHNOLOGY IRELAND UNLIMITED
Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of CancerTRON TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITTSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITT MAINZ GEMEINNTZIGEOct 10, 2024DR H ULRICH DORRIES
Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistSANOFI BIOTECHNOLOGYOct 1, 2024DR H ULRICH DORRIES